MEI Gets Another Chance At PI3K Inhibitor With Infinity Merger

 
• By Joseph Haas
  
M&A
MEI and Infinity announce the latest merger of smaller, clinical-stage biotechs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business